P1134: OUTCOMES FOR PATIENTS WITH MANTLE CELL LYMPHOMA POST-CBTK INHIBITOR THERAPY IN THE UNITED STATES AND JAPAN: A STUDY OF TWO REAL-WORLD DATABASES

por Rai, S., Hess, L., Chen, Y., Abada, P., Konig, H., Walgren, R., Tanizawa, Y., Cai, Z., Tajimi, M.
Publicado 2022

Discovery and characterization of LY2784544, a small-molecule tyrosine kinase inhibitor of JAK2V617F

por Ma, L, Clayton, J R, Walgren, R A, Zhao, B, Evans, R J, Smith, M C, Heinz-Taheny, K M, Kreklau, E L, Bloem, L, Pitou, C, Shen, W, Strelow, J M, Halstead, C, Rempala, M E, Parthasarathy, S, Gillig, J R, Heinz, L J, Pei, H, Wang, Y, Stancato, L F, Dowless, M S, Iversen, P W, Burkholder, T P
Publicado 2013